| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Applying Beta Distribution in Analyzing Bounded Outcome Score Data
|
Hu, Chuanpu
|
|
|
22 |
3 |
|
artikel
|
| 2 |
A Translational Physiologically Based Pharmacokinetics/Pharmacodynamics Framework of Target-Mediated Disposition, Target Inhibition and Drug–Drug Interactions of Bortezomib
|
Iwasaki, Shinji
|
|
|
22 |
3 |
|
artikel
|
| 3 |
Clinical Immunogenicity Risk Assessment for a Fusion Protein
|
Sperinde, Gizette
|
|
|
22 |
3 |
|
artikel
|
| 4 |
Clinical Immunogenicity Risk Assessment Strategy for a Low Risk Monoclonal Antibody
|
Kernstock, Robert
|
|
|
22 |
3 |
|
artikel
|
| 5 |
Comparison of Alternative Population Modeling Approaches for Implementing a Level A IVIVC and for Assessing the Time-Scaling Factor Using Deconvolution and Convolution-Based Methods
|
Gomeni, Roberto
|
|
|
22 |
3 |
|
artikel
|
| 6 |
Correction to: Development and Utility of an ELISA Method for Sensitive and Specific Detection of IgE Antidrug Antibodies
|
Jiang, Lynn L.
|
|
|
22 |
3 |
|
artikel
|
| 7 |
Development of a FRET-Based Assay for Analysis of mAbs Internalization and Processing by Dendritic Cells in Preclinical Immunogenicity Risk Assessment
|
Wen, Yi
|
|
|
22 |
3 |
|
artikel
|
| 8 |
Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption
|
Eriksson, Johanna
|
|
|
22 |
3 |
|
artikel
|
| 9 |
Immunogenicity Risk Assessment for an Engineered Human Cytokine Analogue Expressed in Different Cell Substrates
|
Chamberlain, Paul
|
|
|
22 |
3 |
|
artikel
|
| 10 |
Machine Learning Analysis of Individual Tumor Lesions in Four Metastatic Colorectal Cancer Clinical Studies: Linking Tumor Heterogeneity to Overall Survival
|
Vera-Yunca, Diego
|
|
|
22 |
3 |
|
artikel
|
| 11 |
Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications
|
LaCount, Terri D.
|
|
|
22 |
3 |
|
artikel
|
| 12 |
Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients
|
Karas, Spinel
|
|
|
22 |
3 |
|
artikel
|
| 13 |
Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
|
Zhang, Erhui
|
|
|
22 |
3 |
|
artikel
|
| 14 |
Structure-Based Design and Discovery of a Long-Acting Cocaine Hydrolase Mutant with Improved Binding Affinity to Neonatal Fc Receptor for Treatment of Cocaine Abuse
|
Zheng, Fang
|
|
|
22 |
3 |
|
artikel
|
| 15 |
Subcutaneous Site-of-Absorption Study with the Monoclonal Antibody Tocilizumab in Minipigs: Administration Behind Ear Translates Best to Humans
|
Richter, Wolfgang F.
|
|
|
22 |
3 |
|
artikel
|
| 16 |
Why Do the Majority of Submissions for Bridging from a Prefilled Syringe to an Autoinjector Include Bioequivalence Studies in Order to Demonstrate Comparability?
|
Lambert, William J.
|
|
|
22 |
3 |
|
artikel
|
Tijdschrift beschrijving